OU’s Phi Gamma Delta chapter, commonly known as FIJI, has come to a new educational agreement with the university following multiple alcohol and hazing strikes from last year.
February 14, 2025 - IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, yesterday presented ...
NEW YORK - IN8bio, Inc. (Nasdaq: INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies with a current market capitalization of $23.42 million, has announced encouraging Phase ...
IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...
GlobalData on MSN1d
TC BioPharm completes dosing in Cohort A of Phase IIb trial for AMLThe trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.
As the clock struck 1 p.m. on Thursday, the rhythm of grocery carts resonated throughout the lobby of Wesley House as ...
CHEYENNE – Upsilon Chapter of Delta Kappa Gamma will hold its 41st book sale next month in the former Big Lots in Cheyenne Plaza, 3501 E. Lincolnway, next to Trampoline ...
TC BioPharm (NASDAQ: TCBP) announced the completion of patient dosing in Cohort A of its ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 for re ...
No adverse events related to TCB008 have occurred Evidence of stable disease following TCB008 infusion EDINBURGH, Scotland, Feb. 13, 2025 /PRNewswire/ -- TC ...
PLC ("TC BioPharm" or the "Company") a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has ...
A resolution has been filed in the Arkansas House of Representatives to recognize Delta Sigma Theta Sorority, Inc., for its role in the women’s suffrage movement and its continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback